Back
Direxion Daily Real Estate Bull 3X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
55
DRN
Direxion Daily Real Estate Bull 3X ETF
Last Price:
12.40
Seasonality Move:
14.12%
Sell
41
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
63.02
Seasonality Move:
14.04%
Buy
55
Direxion Daily Real Estate Bull 3X ETF (DRN)
is a Buy
Is Direxion Daily Real Estate Bull 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily Real Estate Bull 3X ETF [DRN] share price is $11.94. The Score for DRN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- DRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $61.89. The Score for BIB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRN Stock Price Chart
What is Direxion Daily Real Estate Bull 3X ETF's stock price today?
-
The Direxion Daily Real Estate Bull 3X ETF share price today is $11.94
The current trend is relatively stagnant and DRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $61.89
The current trend is relatively stagnant and BIB is experiencing slight buying pressure.
DRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 42.4 | Sell |
| Chaikin Money Flow: | 567515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.09 - 13.03) | Sell |
| Bollinger Bands (100): | (9.72 - 13.04) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.61 | Sell |
| Relative Strength Index (14 RSI): | 45.52 | Sell |
| Chaikin Money Flow: | 1425 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.27 - 64.09) | Sell |
| Bollinger Bands (100): | (60.51 - 66.51) | Sell |
DRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.39 | Sell |
| 20-day SMA: | 12.54 | Sell |
| 50-day SMA: | 12.79 | Sell |
| 200-day SMA: | 10.09 | Buy |
| 8-day EMA: | 12.24 | Sell |
| 20-day EMA: | 12.51 | Sell |
| 50-day EMA: | 12.36 | Sell |
| 200-day EMA: | 10.7 | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.91 | Sell |
| 20-day SMA: | 62.82 | Sell |
| 50-day SMA: | 64.06 | Sell |
| 200-day SMA: | 59.77 | Buy |
| 8-day EMA: | 61.99 | Sell |
| 20-day EMA: | 62.64 | Sell |
| 50-day EMA: | 63.25 | Sell |
| 200-day EMA: | 60.22 | Buy |
Direxion Daily Real Estate Bull 3X ETF Earnings Growth & DRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Real Estate Bull 3X ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||